According to Report, the global defibrillator market size is expected to reach USD 20.8 billion by 2030 from valued at USD 10.35 billion in 2020, registering a CAGR of 7.5% from 2022 to 2030.
According to Report, the global defibrillator market size is expected to reach USD 20.8 billion by 2030 from valued at USD 10.35 billion in 2020, registering a CAGR of 7.5% from 2022 to 2030.
The key drivers for this market include supportive regulatory policies, rising incidences of sudden cardiac arrests, product developments, and rising awareness regarding cardiac conditions. The COVID-19 pandemic, however, gave rise to several challenges such as dampened demand for ICDs, logistical bottlenecks, postponed elective surgeries across the globe, and reduced sales growth.
The demand for ICDs plunged during 2020 as governments in many key markets implemented movement restrictions and hospitals deferred elective procedures. The sales recovered gradually as movement restrictions were eased and elective procedure volume went up. For instance, Abbott reported a decline in demand and sales of its cardiovascular and neuromodulation portfolio in 2020. Abbott attributed the sales decrease to reduced procedure volumes resulting from the pandemic.
Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39101
Report Coverage
| Report Scope | Details |
| Market Size | US$ 20.8 billion by 2030 |
| Growth Rate | CAGR of 7.5% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Medtronic; Abbott; Boston Scientific Corporation; BIOTRONIK SE & Co. KG; MicroPort Scientific Corporation; Koninklijke Philips N.V.; Stryker; ZOLL Medical Corporation (Asahi Kasei); Nihon Kohden Corporation; Schiller AG |
By End-use Analysis
Hospitals held the largest revenue share of over 80.0% in 2021. This is owing to the higher number of cardiac patients received in hospitals and surgeries performed in hospital settings.
The public access market segment is anticipated to register the fastest growth rate of 9.6% over the forecast period due to the rising initiatives to increase the availability of public access AEDs, train personnel, and improve response to sudden cardiac arrest events.
By Product Analysis
Implantable cardioverter defibrillators (ICDs) dominated the market with a share of over 70.0% in 2021. The key factors driving this segment include the growing adoption of these devices due to the high prevalence of cardiovascular diseases, the high geriatric population in key markets, and growing product improvements by major companies.
The external defibrillators segment is anticipated to register the fastest growth rate of 9.3% over the forecast period. This is due to technological advancements and initiatives promoting access to AEDs in public places. A bill to enhance availability and access to AEDs (Public Access) in the U.K. is in the pipeline.
Ask here for more details@ https://www.visionresearchreports.com/report/enquiry/39101
By Regional Analysis
North America held the largest revenue share of more than 35.0% in 2021. The growth of the North American market can be attributed to the initiatives by key players, favorable regulations, and technologically advanced healthcare facilities in the U.S. and Canada.
Asia Pacific is projected to expand at the fastest CAGR of 7.9% over the forecast period. This is owing to developing healthcare infrastructure, high patient population, and prevalence of cardiac diseases.
Key Players
- Medtronic
- Abbott
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- MicroPort Scientific Corporation
- Koninklijke Philips N.V.
- Stryker
- ZOLL Medical Corporation (Asahi Kasei)
- Nihon Kohden Corporation
- Schiller AG
Market Segmentation
- By Product
- Implantable Cardioverter Defibrillators (ICD)
- Single Chamber
- Dual Chamber
- CRT-D
- S-ICD
- T-ICD
- External Defibrillators (ED)
- Manual ED
- Automated ED
- Wearable Cardioverter Defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- By End-use
- Hospital
- Pre Hospital
- Public Access Market
- Alternate Care Market
- Home Healthcare
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- MEA
- South Africa
- Saudi Arabia
- UAE
- North America
Click Here to View Full Report Table of Contents
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39101
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333